FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386475196> ?p ?o ?g. }

• W4386475196 abstract "Steroid-free immunosuppression protocols gained popularity in pediatric liver transplantation (pLT) after the introduction of IL-2–receptor blockade for induction therapy. We analyzed the clinical and immunologic outcome data of the multicenter prospective observational ChilSFree study to compare the impact of steroid-free versus steroid-containing immunosuppressive therapy following pLT in a real-life scenario. Two hundred forty-six children [55.3% male, age at pLT median: 2.4 (range: 0.2–17.9) y] transplanted for biliary atresia (43%), metabolic liver disease (9%), acute liver failure (4%), hepatoblastoma (9%), and other chronic end-stage liver diseases (39%) underwent immune monitoring and clinical data documentation over the first year after pLT. Patient and graft survival at 1 year was 98.0% and 92.7%, respectively. Primary immunosuppression was basiliximab induction followed by tacrolimus (Tac) monotherapy (55%), Tac plus steroid tapering over 3 months (29%), or cyclosporine and steroid tapering (7%). One center used intraoperative steroids instead of basiliximab followed by Tac plus mycophenolate mofetil (7% of patients). N = 124 biopsy-proven T-cell–mediated rejections were documented in n = 82 (33.3%) patients. T-cell–mediated rejection occurred early (median: 41 d, range: 3–366 d) after pLT. Patients initially treated with Tac plus steroids experienced significantly fewer episodes of rejection than patients treated with Tac alone (chi-square p <0.01). The use of steroids was associated with earlier downregulation of proinflammatory cytokines interferon (IFN)-γ, Interleukin (IL)-6, CX motif chemokin ligand (CXCL)8, IL-7, and IL-12p70. Both primary immunosuppression with Tac plus steroids and living donor liver transplantation were independent predictors of rejection-free survival 1 year after pLT on logistic regression analysis. Adjunctive steroid therapy after pLT leads to earlier suppression of the post-pLT proinflammatory response and significantly reduced rejection rates during the first year after pLT (15.9%). Fifty-one percent of patients initially treated without steroids remain steroid-free over the first 12 months without rejection." @default.
• W4386475196 created "2023-09-07" @default.
• W4386475196 creator A5003219968 @default.
• W4386475196 creator A5006405927 @default.
• W4386475196 creator A5008307717 @default.
• W4386475196 creator A5008682524 @default.
• W4386475196 creator A5018583602 @default.
• W4386475196 creator A5022592411 @default.
• W4386475196 creator A5023124873 @default.
• W4386475196 creator A5036777432 @default.
• W4386475196 creator A5041418452 @default.
• W4386475196 creator A5046606471 @default.
• W4386475196 creator A5050339660 @default.
• W4386475196 creator A5051091480 @default.
• W4386475196 creator A5053823960 @default.
• W4386475196 creator A5055875110 @default.
• W4386475196 creator A5066232501 @default.
• W4386475196 creator A5066627009 @default.
• W4386475196 creator A5073711492 @default.
• W4386475196 creator A5078486101 @default.
• W4386475196 creator A5083896047 @default.
• W4386475196 date "2023-09-05" @default.
• W4386475196 modified "2023-10-16" @default.
• W4386475196 title "Early steroids after paediatric liver transplantation protect against T-cell mediated rejection –results from the ChilSFree study" @default.
• W4386475196 cites W1480243656 @default.
• W4386475196 cites W1990755377 @default.
• W4386475196 cites W1997746871 @default.
• W4386475196 cites W1997881531 @default.
• W4386475196 cites W2013522986 @default.
• W4386475196 cites W2022671737 @default.
• W4386475196 cites W2031531120 @default.
• W4386475196 cites W2036845344 @default.
• W4386475196 cites W2043470774 @default.
• W4386475196 cites W2047893504 @default.
• W4386475196 cites W2070401728 @default.
• W4386475196 cites W2071743324 @default.
• W4386475196 cites W2075959531 @default.
• W4386475196 cites W2082640593 @default.
• W4386475196 cites W2097938936 @default.
• W4386475196 cites W2111250144 @default.
• W4386475196 cites W2118431104 @default.
• W4386475196 cites W2134344325 @default.
• W4386475196 cites W2170806666 @default.
• W4386475196 cites W2287113864 @default.
• W4386475196 cites W2318734548 @default.
• W4386475196 cites W2802290754 @default.
• W4386475196 cites W2805564530 @default.
• W4386475196 cites W2998041306 @default.
• W4386475196 cites W3081675250 @default.
• W4386475196 cites W3091884291 @default.
• W4386475196 cites W3123832699 @default.
• W4386475196 cites W3134811338 @default.
• W4386475196 cites W3197938986 @default.
• W4386475196 cites W3201447438 @default.
• W4386475196 cites W4210726452 @default.
• W4386475196 cites W4224308355 @default.
• W4386475196 cites W4372319347 @default.
• W4386475196 doi "https://doi.org/10.1097/lvt.0000000000000255" @default.
• W4386475196 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37678230" @default.
• W4386475196 hasPublicationYear "2023" @default.
• W4386475196 type Work @default.
• W4386475196 citedByCount "0" @default.
• W4386475196 crossrefType "journal-article" @default.
• W4386475196 hasAuthorship W4386475196A5003219968 @default.
• W4386475196 hasAuthorship W4386475196A5006405927 @default.
• W4386475196 hasAuthorship W4386475196A5008307717 @default.
• W4386475196 hasAuthorship W4386475196A5008682524 @default.
• W4386475196 hasAuthorship W4386475196A5018583602 @default.
• W4386475196 hasAuthorship W4386475196A5022592411 @default.
• W4386475196 hasAuthorship W4386475196A5023124873 @default.
• W4386475196 hasAuthorship W4386475196A5036777432 @default.
• W4386475196 hasAuthorship W4386475196A5041418452 @default.
• W4386475196 hasAuthorship W4386475196A5046606471 @default.
• W4386475196 hasAuthorship W4386475196A5050339660 @default.
• W4386475196 hasAuthorship W4386475196A5051091480 @default.
• W4386475196 hasAuthorship W4386475196A5053823960 @default.
• W4386475196 hasAuthorship W4386475196A5055875110 @default.
• W4386475196 hasAuthorship W4386475196A5066232501 @default.
• W4386475196 hasAuthorship W4386475196A5066627009 @default.
• W4386475196 hasAuthorship W4386475196A5073711492 @default.
• W4386475196 hasAuthorship W4386475196A5078486101 @default.
• W4386475196 hasAuthorship W4386475196A5083896047 @default.
• W4386475196 hasConcept C126322002 @default.
• W4386475196 hasConcept C2779609443 @default.
• W4386475196 hasConcept C2780252810 @default.
• W4386475196 hasConcept C2781307858 @default.
• W4386475196 hasConcept C2909675724 @default.
• W4386475196 hasConcept C2911091166 @default.
• W4386475196 hasConcept C71924100 @default.
• W4386475196 hasConcept C90924648 @default.
• W4386475196 hasConceptScore W4386475196C126322002 @default.
• W4386475196 hasConceptScore W4386475196C2779609443 @default.
• W4386475196 hasConceptScore W4386475196C2780252810 @default.
• W4386475196 hasConceptScore W4386475196C2781307858 @default.
• W4386475196 hasConceptScore W4386475196C2909675724 @default.
• W4386475196 hasConceptScore W4386475196C2911091166 @default.
• W4386475196 hasConceptScore W4386475196C71924100 @default.
• W4386475196 hasConceptScore W4386475196C90924648 @default.
• W4386475196 hasLocation W43864751961 @default.
• W4386475196 hasLocation W43864751962 @default.

• next